Posted on 9/11/19
John Halamka, MD Joins PatientPing Advisory Board
PatientPing, the nation's leading care collaboration platform, today announced that John D. Halamka, MD, MS, has joined the company as a strategic advisor. An established physician . . .
Posted on 9/10/19
HeathcareSource Appoints Michael Grossi as CEO
HealthcareSource®, the leading provider of talent management solutions for the healthcare industry, today announced
Posted on 9/10/19
Robert Cardillo Joins the Analytical Space Advisory Board
Analytical Space, Inc. (ASI) today announced the appointment of Robert Cardillo, the former Director of the National Geospatial-Intelligence Agency (NGA)
Posted on 9/10/19
Aeromics Appoints Nobel Laureate Peter Agre To Its Board of Directors
Aeromics, Inc., a privately-held, clinical-stage pharmaceutical company developing first-in-class anti-edema therapies, announced today the appointment of Peter Agre, M.D. to its Board
Posted on 9/10/19
Homesite Group Appoints Grace Meek as CEO
Homesite Group Incorporated (Homesite), a direct, multi-line insurer, announced the appointment of Grace Meek as President and CEO of Homesite Underwriting Managers, Inc.
Posted on 9/9/19
Cerevel Therapeutics Appoints Tony Coles, M.D., as CEO
Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced the appointment of renowned biotechnology leader
Posted on 9/8/19
Harvard Bioscience Elects Alan Edrick to Board of Directors
Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that its Board of Directors has elected Alan Edrick to Harvard Bioscience’s Board of Director
Posted on 9/8/19
PureTech Health Appoints Chris Viehbacher as Interim Chair
PureTech Health plc (LSE: PRTC), today announced that Joichi “Joi” Ito, Ph.D., has stepped down from the board of directors, and current board member
Posted on 9/5/19
SmartPharm Therapeutics Appoints Fred Driscoll to Board
SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment
Posted on 9/5/19
Thermo Fisher Scientific Elects Debora Spar to Board
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has elected Debora Spar
Posted on 9/5/19
Farcast Biosciences Appoints Maneesh Arora as CEO
Farcast Biosciences Inc., an oncology diagnostics company, today announced the appointment of Maneesh K. Arora
Posted on 9/5/19
Aleta Biotherapeutics Appoints Mark Leuchtenberger and Eva-Lotta Allan to Board
NATICK, Mass.--(BUSINESS WIRE)--Aleta Biotherapeutics, a privately held immuno-oncology company focused on transforming cellular therapeutics to allow a broad spectrum of cancer indications to be targeted, today . . .
Posted on 9/5/19
Yumanity Therapeutics Appoints Patricia Allen to Board
Yumanity Therapeutics, a company focused on discovering and developing transformative therapies to treat neurodegenerative
Posted on 9/5/19
MediSpend Names Craig Hauben CEO
MediSpend, a leading provider of global compliance solutions for the life sciences industry, continues the evolution of its leadership team to support growing demand. The company . . .
Posted on 9/5/19
Ethos Appoints Valerie Frias CEO
Ethos today announced that the organization's Board of Directors has appointed Valerie Frias as Chief Executive Officer, succeeding Dale Mitchell,
Posted on 9/4/19
Dominique Mathieu Named to the Board of Directors of South Shore Habitat for Humanity
South Shore Habitat for Humanity (http://sshabitat.org), which has delivered quality housing in partnership with families in need for the past 32 years, has named Dominique Mathieu . . .
Posted on 9/4/19
Lyra Therapeutics Appoints Ann Merrifield to Its Board of Directors
Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines designed to precisely target ear, nose and throat (ENT) diseases,
Posted on 9/4/19
Covetrus Appoints Benjamin Wolin as Chair of its Board of Directors
Covetrus (NASDAQ: CVET),?a global?leader in?animal-health technology and services, today announced the appointment of Benjamin Wolin as chair of its board
Posted on 9/4/19
Epizyme Appoints Victoria Richon, Ph.D., To Board
Epizyme, Inc. (Nasdaq: EPZM), a late-stage biopharmaceutical company developing novel epigenetic therapies, today announced the appointments of experienced commercial executive,
Posted on 9/4/19
J O Hambro Capital Management Appoints Nick Good as CEO
British active asset manager J O Hambro Capital Management (JOHCM)[1]announces the appointment of Nick Good as CEO of its U.S. business.
Posted on 9/3/19
Ramy Ibrahim, M.D. to Join Surface Oncology Board of Directors
CAMBRIDGE, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), today announced Ramy Ibrahim, M.D., will join the company’s board of directors. Dr. Ibrahim is . . .
Posted on 9/2/19
BR Brands Announces Resignation of Mary's Brands CEO Lynn Honderd
BR Brands, LLC, a consumer packaged goods company within the global legal cannabis industry, announced today that Mary's Brands co-founder and CEO
Posted on 9/2/19
SpringWorks Therapeutics Appoints Alan Fuhrman to Its Board of Directors
SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer
Posted on 8/28/19
Chris Lafond Appointed Insurity CEO
Insurity, Inc., a leading provider of cloud-based solutions and data analytics for the world’s largest insurers, brokers
Posted on 8/27/19
Barnes Group Mourns the Passing of Board Member Gary G. Benanav
BRISTOL, Conn.--(BUSINESS WIRE)--Barnes Group Inc. (NYSE: B) today announced the passing of Gary G. Benanav, a longtime member of the Company’s Board of Directors.“All of us . . .
Boston
